Navigation Links
Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
Date:3/19/2013

ion index of 43% compared to the standard Framingham method.

"As a cardiologist, I am excited about the prospect of this test. I understand its value to my patients and practice and I was happy to speak to my colleagues about its usefulness in the clinic," stated Dr. Simonini.

Aviir CEO Douglas Harrington , MD, said Aviir anticipates that the MIRISK VP test will become an important and widely used tool for physicians who want to provide their patients with a clearer picture of their individual heart health by providing critical information to high risk patients who may be incorrectly identified as intermediate risk by standard diagnostic methods.

About the MIRISK VP™ Assessment

The Aviir MIRISK VP test was developed out of research performed at the Stanford University School of Medicine. Researchers identified seven key proteins associated with the biological processes underlying formation and rupture of vulnerable plaque, which is the number one cause of a heart attack. MIRISK VP was shown to effectively measure these proteins in a patient's blood up to 5 years prior to an ensuing heart attack or unstable angina. Aviir's scientists developed sensitive multiplexed assays as well as a proprietary algorithm to detect those key proteins in an individual's blood and combines them with additional clinical risk factors to generate a more accurate 5-year risk score assessment for coronary heart disease (CHD). In an independent study, the MIRISK VP algorithm was shown to reclassify intermediate risk individuals as actually belonging either in a high or low risk group, significantly improving risk stratification (net reclassification index of 43%). By identifying patients who are actually at high risk, MIRISK VP assists physicians in developing effective treatment plans and implementing preventative measures to reduce the risk of a heart attack when they can be most beneficial. When used in conjunction with addi
'/>"/>

SOURCE Aviir Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
2. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
3. Dr. James Douglas Adds Human Growth Hormone (HGH) Therapy to IVF Protocols for Poor Responding Patients
4. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
7. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
8. Sequenom Named to NASDAQ Global Select Market
9. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
10. First Choice Rehabilitation Specialists Joins Select Medical
11. Netsmart Selects Overland Park, Kansas, for New Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... (PRWEB) , ... June 26, 2015 , ... ReliantHeart, ... that indicates that from the first implant of the HeartAssist5® LVAD (HA5) to the ... the HA5. , Thrombus that originates in an LVAD is referred to as ...
(Date:6/25/2015)... (PRWEB) , ... June 25, 2015 , ... ... of keynotes speakers for its 2015 National Patient and Family Conference, Providing and ... in Chicago at the Renaissance Chicago O’Hare Suites Hotel, July 24-25, 2015. , ...
(Date:6/25/2015)... June 25, 2015 ... -Authentifizierungsdienstleistungen, führte am 24. und 25. Juni ... am Main das 2. Eco System Partner ... Thema Sicherheit für Patienten in Europa und ...      (Logo: http://photos.prnewswire.com/prnh/20150610/748687) , Vertreter ...
(Date:6/25/2015)... Nev. , June 25, 2015  PDL BioPharma, Inc. ... P. McLaughlin , the company,s president and chief executive officer, ... in London , England.  The fireside chat-style ... June 30, 2015 at 8:30 a.m. BST / 3:30 a.m. ... webcast of the presentation, go to the Company,s website at ...
Breaking Biology Technology:HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 2HeartAssist5® Remote Monitoring has alerted no patterns of de novo thrombus in 68 consecutive implants 3Nationally Recognized Brain Tumor Experts to Speak at American Brain Tumor Association Patient and Family Conference 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 2Symposium zur Richtlinie über gefälschte Arzneimittel - mit Aegate in Deutschland 3PDL BioPharma to Present at the Nasdaq 32nd Investor Program 2
... 5, 2012  PharmAthene, Inc. (NYSE Amex: PIP ), ... threats, announced today that management will present at the ROTH ... 2012 at 5:30 pm PT at the Ritz-Carlton Laguna Niguel ... ConferenceDate : , Monday, March 12, 2012 at 5:30 pm ...
... difference between salt water and fresh water is most ... bicarbonate salt solution, Penn State researchers can combine bacterial ... salt-water fresh-water gradient to produce power anywhere. "We ... them together," said Bruce E. Logan, Kappe Professor of ...
... -- FirstMark, the diagnostic division of GenWay Biotech, announced ... was held today on March 1, 2012. The Board ... research. The main focus of the Board will be ... of FirstMark,s new cardiovascular test PREvent. PREvent is the ...
Cached Biology Technology:Unique salt allows energy production to move inland 2Inaugural Meeting of the FirstMark Scientific Board of Advisors 2Inaugural Meeting of the FirstMark Scientific Board of Advisors 3
(Date:6/8/2015)... SAN DIEGO , June 8, 2015  Trovagene, Inc. ... announced today that clinical data featuring its Precision Cancer Monitoring ... Cancer Markers and Liquid Biopsies conference in San ... the AACR Precision Medicine Series: Integrating Clinical Genomics and ... on June 13-16. "We continue ...
(Date:6/5/2015)... GERMANTOWN, Md. , June 5, 2015  Intrexon ... synthetic biology, today announced that it has determined the ... of all of its 17,830,305 shares of ZIOPHARM Oncology, ... or about June 12, 2015, the distribution date, as ... stock, and on warrants to purchase shares of Intrexon ...
(Date:6/1/2015)... -- According to a new market research ... (Touch-based & Touchless), Application (Consumer Electronics, Automotive, & Others), ... Global Forecast to 2020", published by MarketsandMarkets, the Gesture ... $23.55 Billion by 2020, at a CAGR of 28.23% ... market data T ables and   86   ...
Breaking Biology News(10 mins):Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 2Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 3Clinical Data Featuring Trovagene's Urine-Based Liquid Biopsy Platform to be Presented at Two Upcoming Medical Conferences 4Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 2Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 3Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares 4Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 2Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 3Gesture Recognition & Touchless Sensing Market Worth $23.55 Billion by 2020 4
... liver disease, extent of tissue damage depends on the balance ... new liver cells. In a significant minority of people who ... form scars. This can progress to chronic liver disease and ... unable to clean blood or produce vital hormones and clotting ...
... a type of cell that can be activated by tissues ... attack our own molecules, cells and organs, UCSF researchers have ... new strategies for fighting a range of autoimmune diseases ... and cells within us as well as for preventing ...
... CHICAGO A low-calorie diet eliminates insulin dependence ... with type 2 diabetes, according to a study presented ... of North America (RSNA). "Lifestyle interventions may have ... patients," said the study,s lead author, Sebastiaan Hammer, M.D., ...
Cached Biology News:The immune system has protective memory cells, researchers discover 2The immune system has protective memory cells, researchers discover 3Restricted calorie diet improves heart function in obese patients with diabetes 2
HybriWell seals securely to a microscope slide surface in seconds to enclose single or multiple specimens in a small reagent volume and eliminate evaporation....
Comp Dim: chamber diam. depth 20 2.8 mm chamber maximum volume 720 μL...
... Human IgM Assay Kit to address the ... assay for Human IgM that eliminates the ... a simple mix-and-read assay that allows the ... ng/ml in approximately 30 minutes. The Pierce ...
AC input: 230 V...
Biology Products: